Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Benoxinate hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxybuprocaine hydrochloride |
Inferred relationship |
Some |
|
Oxybuprocaine poisoning |
Causative agent (attribute) |
False |
Oxybuprocaine hydrochloride |
Inferred relationship |
Some |
|
Accidental oxybuprocaine poisoning |
Causative agent (attribute) |
False |
Oxybuprocaine hydrochloride |
Inferred relationship |
Some |
|
Intentional oxybuprocaine poisoning |
Causative agent (attribute) |
False |
Oxybuprocaine hydrochloride |
Inferred relationship |
Some |
|
Oxybuprocaine poisoning of undetermined intent |
Causative agent (attribute) |
False |
Oxybuprocaine hydrochloride |
Inferred relationship |
Some |
|
Oxybuprocaine adverse reaction |
Causative agent (attribute) |
False |
Oxybuprocaine hydrochloride |
Inferred relationship |
Some |
1 |
Allergy to oxybuprocaine |
Causative agent (attribute) |
False |
Oxybuprocaine hydrochloride |
Inferred relationship |
Some |
|
Oxybuprocaine overdose |
Causative agent (attribute) |
False |
Oxybuprocaine hydrochloride |
Inferred relationship |
Some |
1 |
Accidental oxybuprocaine overdose (disorder) |
Causative agent (attribute) |
False |
Oxybuprocaine hydrochloride |
Inferred relationship |
Some |
1 |
Intentional oxybuprocaine overdose |
Causative agent (attribute) |
False |
Oxybuprocaine hydrochloride |
Inferred relationship |
Some |
1 |
Oxybuprocaine overdose of undetermined intent |
Causative agent (attribute) |
False |
Oxybuprocaine hydrochloride |
Inferred relationship |
Some |
1 |
Oxybuprocaine hydrochloride 0.4% single-use eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxybuprocaine hydrochloride |
Inferred relationship |
Some |
|
Fluorescein sodium and oxybuprocaine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxybuprocaine hydrochloride |
Inferred relationship |
Some |
|
Benoxinate hydrochloride 0.2% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxybuprocaine hydrochloride |
Inferred relationship |
Some |
|
Benoxinate hydrochloride 0.4% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxybuprocaine hydrochloride |
Inferred relationship |
Some |
|
Benoxinate hydrochloride+fluorescein sodium 0.3%/0.125% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxybuprocaine hydrochloride |
Inferred relationship |
Some |
|
Benoxinate hydrochloride+fluorescein sodium 0.4%/0.25% ophthalmic solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxybuprocaine hydrochloride |
Inferred relationship |
Some |
|
Accidental oxybuprocaine poisoning |
Causative agent (attribute) |
False |
Oxybuprocaine hydrochloride |
Inferred relationship |
Some |
|
Intentional oxybuprocaine poisoning |
Causative agent (attribute) |
False |
Oxybuprocaine hydrochloride |
Inferred relationship |
Some |
|
Oxybuprocaine hydrochloride 0.4% conventional release eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxybuprocaine hydrochloride |
Inferred relationship |
Some |
|
Product containing precisely oxybuprocaine hydrochloride 4 milligram/1 milliliter conventional release solution for eye drops (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Oxybuprocaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely oxybuprocaine hydrochloride 4 milligram/1 milliliter conventional release solution for eye drops (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Oxybuprocaine hydrochloride |
Inferred relationship |
Some |
1 |
Oxybuprocaine hydrochloride 4 mg/mL eye drops |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Oxybuprocaine hydrochloride |
Inferred relationship |
Some |
1 |
Oxybuprocaine hydrochloride 4 mg/mL eye drops |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Oxybuprocaine hydrochloride |
Inferred relationship |
Some |
1 |